Literature DB >> 15796179

Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate.

Thomas Efferth1, Manfred Volm.   

Abstract

The anti-malarial artesunate (ART) also inhibits the growth of cancer cells. The active moiety is an endoperoxide bridge whose cleavage generates reactive oxygen species and free radicals. We analyzed whether glutathione-related enzymes contribute to tumor resistance to ART and to the low toxicity of ART towards normal organs. The microarray-based mRNA expression of dihydrodiol dehydrogenase, gamma-glutamylcysteine synthase (gamma-GCS), glutathione S-transferases GSTM4, GSTT2, GSTZ1, and microsomal glutathione S-transferase MGST3 showed significant relationships (p <0.05) to cellular response to ART in 55 cell lines of the National Cancer Institute, USA. A tendency for correlation (0.05<p<0.1) was observed for GSTA1, GSTA2, GSTP1 and MGST1. A further 12 glutathione-related genes were not linked to ART resistance. MSC-HL13 cells transfected with cDNAs for heavy and light subunits of gamma-GCS were more resistant to ART than mock control vector-transfected MSV-PC4 cells. L-buthionine sulfoximine, a gamma-GCS inhibitor that depletes cellular glutathione pools, completely reversed ART resistance in MSV-HL13 cells, while a partial reversion was obtained by ethacrynic acid, an inhibitor of GST. The expression of GST-P was analyzed immunohistochemically in normal rat organs. GST-P immunostaining was found in all organs analyzed, albeit with varying staining intensities and in different histological structures of the organs. GST expression in normal organs may, therefore, contribute to the good tolerability and minimal toxicity of ART in normal organs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15796179

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  13 in total

Review 1.  NRF2, cancer and calorie restriction.

Authors:  A Martín-Montalvo; J M Villalba; P Navas; R de Cabo
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

2.  Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro.

Authors:  S J Kim; M S Kim; J W Lee; C H Lee; H Yoo; S H Shin; M J Park; S H Lee
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-05       Impact factor: 4.553

Review 3.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

4.  Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production.

Authors:  Anne Hamacher-Brady; Henning A Stein; Simon Turschner; Ina Toegel; Rodrigo Mora; Nina Jennewein; Thomas Efferth; Roland Eils; Nathan R Brady
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

5.  Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction.

Authors:  Luke H Stockwin; Bingnan Han; Sherry X Yu; Melinda G Hollingshead; Mahmoud A ElSohly; Waseem Gul; Desmond Slade; Ahmed M Galal; Dianne L Newton; Maja A Bumke
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

6.  Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.

Authors:  Beatrice Bachmeier; Iduna Fichtner; Peter H Killian; Emanuel Kronski; Ulrich Pfeffer; Thomas Efferth
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

Review 7.  A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Authors:  Richard E Kast; John A Boockvar; Ansgar Brüning; Francesco Cappello; Wen-Wei Chang; Boris Cvek; Q Ping Dou; Alfonso Duenas-Gonzalez; Thomas Efferth; Daniele Focosi; Seyed H Ghaffari; Georg Karpel-Massler; Kirsi Ketola; Alireza Khoshnevisan; Daniel Keizman; Nicolas Magné; Christine Marosi; Kerrie McDonald; Miguel Muñoz; Ameya Paranjpe; Mohammad H Pourgholami; Iacopo Sardi; Avishay Sella; Kalkunte S Srivenugopal; Marco Tuccori; Weiguang Wang; Christian R Wirtz; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2013-04

8.  Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.

Authors:  Thomas Efferth; Marco Giaisi; Annette Merling; Peter H Krammer; Min Li-Weber
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

9.  Molecular biology of cantharidin in cancer cells.

Authors:  Rolf Rauh; Stefan Kahl; Herbert Boechzelt; Rudolf Bauer; Bernd Kaina; Thomas Efferth
Journal:  Chin Med       Date:  2007-07-04       Impact factor: 5.455

10.  Ameliorative Effects of Curcumin on Artesunate-Induced Subchronic Toxicity in Testis of Swiss Albino Male Mice.

Authors:  Ketaki R Desai; Dhrupadsinh K Rajput; Pragnesh B Patel; Hyacinth N Highland
Journal:  Dose Response       Date:  2015-06-26       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.